ENTITY
Chugai Pharmaceutical

Chugai Pharmaceutical (4519 JP)

133
Analysis
Health CareJapan
Chugai Pharmaceutical Company Ltd., manufactures and sells pharmaceuticals in the domestic and international markets through its subsidiaries. The Company develops drugs in the fields of cancer, infectious diseases, bone, blood, and circulatory systems. Chugai Pharmaceutical also conducts research studies on drugs with private and public medical research institutions.
more
Refresh
08 Feb 2024 09:30

Chugai Pharmaceutical (4519 JP): Ronapreve Killed Joy in 2023; New Products to Drive Growth Ahead

​Chugai reported 5% decline in 2023 revenue, dragged by Ronapreve. Despite no revenue from Ronapreve, 2024 revenue is expected to decline just 4%...

Logo
225 Views
Share
19 Mar 2024 09:44

Tokio Marine Cross-Shareholding - At Least US$18bn of Cross-Shareholding to Sell

Tokio Marine Holdings (8766 JP) had a stake over US$100m in at least 33 listed Japanese stocks, amounting to a total of US$16.5bn.

Logo
387 Views
Share
bullishDaiichi Sankyo
15 Mar 2024 09:30

Daiichi Sankyo (4568 JP): Second Time FY24 Guidance Raise; Event Heavy FY25 With 2 New Drug Approval

​Daiichi Sankyo raised FY24 revenue, core op. profit, and net profit forecast by 2%, 16%, and 30%, respectively. FDA set action dates for HER3-DXd...

Logo
381 Views
Share
bullishOtsuka Holdings
21 Feb 2024 09:30

Otsuka Holdings (4578 JP): Impairment Charges Bite 2023 Profit; 2024 Guidance Initiated

​Otsuka missed 2023 operating and net profit targets due to impairment loss. 6% YoY growth is expected for 2024 revenue and business profit. Net...

Logo
285 Views
Share
bearishFast Retailing
14 Feb 2024 06:05

Nikkei 225 Index Rebalance Preview (Mar 2024): Update on Ranking, Capping, Funding & Fast Retailing

The stocks have moved a fair bit in the last couple of weeks. The expected deletes are getting sold while the potential adds have moved higher. The...

Logo
962 Views
Share
x